|1.||Ferrero, Maria Elena: 1 article (01/2014)|
|2.||Fulgenzi, Alessandro: 1 article (01/2014)|
|3.||De Giuseppe, Rachele: 1 article (01/2014)|
|4.||Bamonti, Fabrizia: 1 article (01/2014)|
|5.||Marcolongo, R: 1 article (10/2007)|
|6.||Baldi, F: 1 article (10/2007)|
|7.||Nieddu, M E: 1 article (10/2007)|
|8.||Frediani, B: 1 article (10/2007)|
|9.||Menza, L: 1 article (10/2007)|
10/01/2007 - "To assess the efficacy of Cellfood's therapy in the treatment of fibromyalgia. "
10/01/2007 - "[Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia]."
10/01/2007 - "Our result suggest that the Cellfood's therapy improve fibromyalgia symptoms and health-related quality of life."
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
01/01/2014 - "Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment."
01/01/2014 - "This prospective pilot study aimed at evaluating the effects of therapy with antioxidant compounds (Cellfood, and other antioxidants) on patients affected by neurodegenerative diseases (ND), who displayed toxic metal burden and were subjected to chelation treatment with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNa2EDTA or EDTA). "
|1.||Edetic Acid (EDTA)